NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression.

Tikhomirova, Mariya; Topchu, Iuliia; Mazitova, Aleksandra; Barmin, Vitaly; Ratner, Ekaterina; Sabirov, Alexey; Abramova, Zinaida; Deneka, Alexander Y

Tikhomirova, Mariya; Topchu, Iuliia; Mazitova, Aleksandra; Barmin, Vitaly; Ratner, Ekaterina; Sabirov, Alexey; Abramova, Zinaida; Deneka, Alexander Y.

Afiliación

Tikhomirova M; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.
Topchu I; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.
Mazitova A; Feinberg School of Medicine, Northwestern University, Chicago, IL 60610, USA.
Barmin V; Institute of Fundamental Medicine and Biology, Kazan Federal University, 420000 Kazan, Russia.
Ratner E; Department of Medicine and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Sabirov A; Moscow P.A. Gertsen Oncological Research Institute, 125284 Moscow, Russia.
Abramova Z; Republican M.Z.Sigal Clinical Oncology Hospital, 420029 Kazan, Russia.
Deneka AY; Republican M.Z.Sigal Clinical Oncology Hospital, 420029 Kazan, Russia.

Cancers (Basel) ; 14(10)2022 May 20.

Article en En | MEDLINE | ID: mdl-35626121

Palabras clave

CHK2; DNA damage response; ERCC4; HEF1; non-small cell lung cancer; overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Rusia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google